
“Obstetrics, Gynecology and Reproduction” (“Akuserstvo, Ginekologia i Reprodukcia”) is a scientific and practical peer-reviewed journal for obstetricians, gynecologists and other experts in the area of women’s health. Our aims and priorities focus on scientific and information support to the members of the "professional community" in their pursuit of new ideas in obstetrics and gynecology research. In addition, the AGR journal proudly contributes to the continuing medical education (CME) of practitioners who specialize in various areas of women’s health including obstetrics, gynecology, in vitro fertilization (IVF) and assisted reproductive technology (ART).
“Obstetrics, Gynecology and Reproduction” (“Akuserstvo, Ginekologia i Reprodukcia”) was founded in 2007
The impact factor of this journal, as shown in the Russian Science Citation Index (RSCI) is among the highest for the periodicals on obstetrics, gynecology, perinatology and problems of women’s health. According to RSCI, the biennial impact factor was 0.509 in 2013, 0.810 in 2014, and 0.976 in 2015.
The journal publishes original articles on clinical and experimental studies, as well as reviews on obstetrics, gynecology, and human reproduction. Special attention is paid to publications on CME as well as historic aspects of obstetrics and gynecology. All manuscripts, both original research and literature reviews, are published upon a mandatory peer-review.
Languages: Russian, English
Periodicity: 6 issues per year.
The printed versions are distributed under the Creative Commons Attribution 4.0 License: full-text materials are freely available to the public in an open access repository.
Distribution of the printed version: Russia, the EurAsian Economic Community (EurAsEC) countries (Belarus, Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan, Armenia, Moldova), Ukraine, Georgia.
The editorial board of “Obstetrics, Gynecology and Reproduction” (“Akuserstvo, Ginekologia i Reprodukcia”) includes leading scientists from Russia, Austria, Great Britain, Israel, USA, Croatia, Ukraine, Georgia, and Uzbekistan.
The editorial board of this journal maintains the policy of full compliance with all principles of publishing ethics. Our ethical standards and codes conform to those of top international science publishers.
All submitted materials undergo a mandatory double-blind peer review.
Media Certificate of Registration: ПИ №FS77-34885 of December 29, 2008.
ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)
By the decision of the Higher Attestation Commission (HAC) of Russia, “Obstetrics, Gynecology and Reproduction” (“Akuserstvo, Ginekologia i Reprodukcia”) is included in the "List of top peer-reviewed scientific journals and publications" where scientists seeking academic degrees are required to publish their results.
The “Obstetrics, Gynecology and Reproduction” (“Akuserstvo, Ginekologia i Reprodukcia”) journal appears in the Russian Universal Scientific Electronic Library (RUNEB) elibrary.ru and is also present in the database of the Russian Science Citation Index (RSCI). Concise versions of major articles from this journal are published by the All-Russian Institute for Scientific and Technical Information (VINITI). The journal is also indexed by "Ulrich's periodicals Directory" – a global information system of periodicals and continued publications.
Current issue
EDITORIAL
The journal brings together original research and analytical reviews devoted to the latest advances in obstetrics, gynecology, and reproductive medicine. The materials presented consider key issues of fertility preservation in cancer patients and the pathogenetic mechanisms of obstetric complications. They also cover innovative methods of diagnosing and treating gynecological diseases. Particular attention is paid to interdisciplinary aspects and personalized patient care, making use of the advances in molecular medicine and artificial intelligence. Articles combine fundamental research with clinical trials, offering new opportunities to enhance diagnostic and therapeutic strategies and contribute to the advancement of reproductive medicine as a multidisciplinary field.
ОRIGINAL ARTICLES
What is already known about this subject?
► The number of women aged above 30 years old giving birth has been increasing.
What are the new findings?
► The age of primiparous mothers in the Euro-Arctic zone of Russia is higher than the national average level.
► Of the diseases that can affect the course of pregnancy and fetal health, infectious diseases of the genitourinary system prevail, which occur in every fifth pregnant woman.
► In the anamnesis, half of pregnant women have cervical erosion (ectropion) previously subjected to diathermocoagulation. The number of cesarean section deliveries in this region exceeded the Russia-wide average level by 13.5 %.
How might it impact on clinical practice in the foreseeable future?
► While carrying out therapeutic and preventive measures, it is necessary to take into account the regional features on female reproductive system morbidity exceeding the regional and Russia-wide average levels.
► Special attention should be paid to primary assessment of pregnancy risk factors, which revealed significant age differences between women under 30 and older than 35 years of age.
► The burdened obstetric and gynecological history is accounted for by increased percentage of pregnant women over the age of 35 and the early onset of sexual relations.
Aim: identification of the features specific to course of pregnancy, childbirth and reproductive behavior of women in the Arctic zone of the Russian Federation.
Materials and Methods. A retrospective content analysis was conducted to assess information from individual medical records (2019) of pregnant and postpartum women (n = 91) retrieved from the archive of the Hospital of the Kola Science Center of RAS and statistical data provided by the medical information and analytical center as well as Bayandin Murmansk Regional Clinical Hospital (1998–2018). Three study groups were stratified: women aged under 30 years, 30–35 years, and above 35 years old. An assessment of the primary risks of pregnancy and childbirth in different age groups was carried out. An analysis of childbirth outcome was performed. Differences were considered significant at p ≤ 0.05 level (assessed by Mann–Whitney U-test).
Results. The article presents significant differences while assessing perinatal and biological risk factors in women above 35 years of age compared to those under 30 years old and subjects ranged from 30 to 35 years of age (p < 0.019). The ratios of the identified factors that can affect course of pregnancy and childbirth are revealed. The most common pregnancy complications were found to be a threat of early-stage miscarriage (30.0 %) and anemia of pregnant women (25.0 %), diseases of the urinary tract (18.7 %). Pregnancy ended by cesarean section in 30.7 % of women, whereas primiparous women older 35 years it reached 57.1 %.
Conclusion. The course of pregnancy and childbirth in women living in the Arctic zone of the Russian Federation is affected by complementary effects of widespread, negative risk factors (in-pregnancy diseases, burdened obstetric history, social factors), as well as specific climatic and geographical conditions of the living environment (cold exposure, unique circadian rhythm, heliogeomagnetic features). In addition to the above-mentioned causes affecting the course of pregnancy and fetal development, the most significant are also presented by infectious diseases of the urinary tract. Among the endogenous risk factors during pregnancy and childbirth, the predominant risk factors are pregnancy complications such as a threat of early pregnancy termination and anemia. The negative trend of increase in the number of primiparous women older 30 years of age is confirmed.
What is already known about this subject?
► Preeclampsia (РЕ) is a significant issue in obstetrics and gynecology, as it is a leading cause of maternal and neonatal morbidity and mortality.
► Even with risk factors such as high blood pressure and obesity, not all pregnant women develop PE and related complications. This highlights the importance of identifying additional predisposing factors that may profoundly increase a risk of severe PE and require more careful pregnancy monitoring.
What are the new findings?
► The marked differences identified in age, body mass index, presence of chronic arterial hypertension, and altered ophthalmic artery blood circulation, which mirror cerebral blood flow parameters in pregnant women, underscore the role for such factors as РЕ predictors.
► PSV2/PSV1 pick systolic velocities ratio in patients at high PE risk showed its potential value for the early РЕ risk assessment.
How might it impact on clinical practice in the foreseeable future?
► The study results may significantly improve early diagnostics and management of PE risks. The implementation of Doppler ultrasound to assess ophthalmic artery blood flow parameters during early pregnancy will allow for more accurate identification of women at high РЕ risk and provide an opportunity for timely intervention.
Aim: to study ophthalmic artery blood flow parameters for predicting preeclampsia (РЕ) development, as well as compare prognostic value of their changes with calculated PE risk during prenatal screening.
Materials and Methods. A prospective cohort comparative study was conducted by enrolling 80 pregnant women divided into two groups: per 40 subjects at high or low РЕ risk based on first-trimester prenatal screening assigned to main group and control group, respectively. Ophthalmic artery blood flow parameters (assessing the average magnitude from right and left examined vessels) was conducted from 11 to 13⁺⁶ weeks of pregnancy using Doppler ultrasound. Peak systolic velocity 1 (PSV1), peak systolic velocity 2 (PSV2), pulsatility index, and resistance index were assessed. Analysis of pregnancy course and outcomes was carried out.
Results. In main group (high РЕ risk), 27 (67.5 %) patients had a normal course of pregnancy and term delivery (38–40 weeks). The remaining patients experienced hypertensive disorders and РЕ. Of the 40 women in main group, 25 (62.5 %) had vaginal deliveries, while 15 (37.5 %) underwent cesarean section (СS), 13 (86.7 %) subjects of those had indications related to РЕ and fetal growth restriction (FGR). In control group (low РЕ risk), 38 (95.0 %) women also had term delivery, with 31 (77.5 %) subjects having vaginal delivery and 9 (22.5 %) undergoing СS for indications unrelated to РЕ and FGR. Of the 80 patients from both study groups, РЕ developed in 10 (12.5 %) subjects: 2 cases (5.0 %) in low-risk PE group and 8 (20.0 %) in high-risk PE group. Early-onset РЕ (before 34 weeks of gestational age) was diagnosed in 2 patients (20.0 %) out of 10, whereas late-onset РE (after 34 weeks of gestational age) was diagnosed in 8 (80.0 %) subjects suggesting late PE predominance (ratio 1:4). PSV1 magnitude tended to insignificantly increase in control group. Pulsatility and resistance indices also did not reveal significant differences. In patients at high vs. low PE risk, the PSV2/PSV1 ratio was 8.0 % higher, but these differences were insignificant (p > 0.05), and among those pregnant women who developed PE, the PSV2/PSV1 ratio was significantly higher (p < 0.001) compared to group without PE.
Conclusion. The study results evidence about the importance of evaluating ophthalmic artery blood flow parameters in pregnant women during the first prenatal screening as an additional tool for predicting PE.
What is already known about this subject?
► Haemostasis аctivation promotes tumour growth and metastasis by forming a fibrin matrix, activating platelets, and protecting tumour cells from the immune system.
► Venous thromboembolism in cancer patients is associated with a more aggressive tumour progression and higher risk of recurrence.
► Some anticoagulants have been shown to demonstrate antitumour activity in preclinical models by influencing the angiogenesis, tumour cell invasion and migration.
What are the new findings?
► For the first time, clinical data has shown that anticoagulants are not only effective in preventing thrombosis, but also in lowering recurrence rate when used long term.
► The traditional approach to using anticoagulants in oncology is being questioned, primarily focusing on their potential antitumour effect in adjuvant therapy.
► The potential of anticoagulants to modify the tumour microenvironment and metastasis in patients with advanced ovarian cancer has been validated.
How might it impact on clinical practice in the foreseeable future?
► The study results may contribute to expanding indications for long-term anticoagulant therapy to treat more patients with ovarian cancer, particularly those at high risk of thrombotic complications and tumour progression.
► The research may encourage introduction of prospective monitoring of anticoagulants-related effects on recurrence rates and tumour microenvironment formation within clinical protocols.
► The study suggests that the role of anticoagulants in modifying course of malignant processes should be revisited, which could transform an approach to manage patients with advanced cancer.
Aim: to perform a comparative analysis of epithelial ovarian cancer (ОС) recurrence rate in patients with/without long-term anticoagulant therapy (АСТ) as a part of secondary prevention of thrombotic complications.
Materials and Methods. A prospective interventional non-randomized comparative study was conducted with 126 stage III–IV epithelial ОС patients. Main group patients (n = 66) received long-term АСТ (60–72 months) for secondary prevention of venous thromboembolic complications, while comparison group patients (n = 60) received no АСТ. Both groups were comparable in patient age, disease stage and amount of anticoagulant treatment. There were used direct oral anticoagulants: dabigatran, rivaroxaban and apixaban. ОС recurrence and thrombotic complications rate were assessed.
Results. OC recurrence rate was found to be 31.8 % (n = 21) in main group and 65 % (n = 39) in comparison group (p < 0.05). The incidence of thrombotic complications was comparable between groups: 18.2 % versus 16.7 % respectively. The data show a significant decline in OC recurrence risk upon long-term АСТ.
Conclusion. Long-term АСТ in patients with epithelial OC to prevent recurrent thrombosis may exert additional antitumour effect. The observed decline in OC recurrence rate supports the hypothesis that the haemostatic system is involved in the mechanisms of tumour invasion and metastasis. Further randomized trials are needed to evaluate efficacy of anticoagulants as potential modifiers of malignant neoplasm progression.
What is already known about this subject?
► Recurrent pregnancy loss (RPL) is one of the most serious and socially significant complications of pregnancy.
► The central arms in RPL pathogenesis are coupled to immune disorders and dysregulated pineal-pituitary-adrenal axis.
► Previous studies provide convincing evidence regarding alterations in the intestinal microbiota in women with RPL.
What are the new findings?
► It has been shown that pregnant women with former RPL are characterized by lower α-diversity of the bacterial community.
► The pattern of the taxonomic composition for intestinal micro-biota in patients with RPL at delivery level has been clarified.
► Statistically significant correlations between some bacterial genera and systemic levels of neuro-immune-humoral biomarkers have been established.
How might it impact on clinical practice in the foreseeable future?
► The role of intestinal dysbiosis as a crucial contributor in RPL pathogenesis has been verified.
► Targeted impact on the intestinal microbiota may contribute to improve effectiveness of therapeutic approaches in RPL treatment.
Aim: to study taxonomic diversity of the intestinal microbiome landscape in relation to neuro-immune-humoral biomarkers in patients with recurrent pregnancy loss (RPL).
Materials and Methods. A cross-sectional comparative study was conducted by enrolling 55 pregnant women with history of RPL (main group) and 60 women with physiological pregnancy (control group). All women underwent serum tumor necrosis factor-alpha (TNF-α), interleukin (IL) IL-17, cortisol and melatonin levels assessment using enzyme-linked immunosorbent assay. The taxonomic composition of the intestinal microbiota at the birth level was examined using 16S ribosomal RNA gene sequencing. The Chao1, Sobs, and ACE (Abundance Coverage Estimator) indices were used to assess α-diversity of microbial community.
Results. It was found that α-diversity of the bacterial community in patients with RPL was significantly decreased assessed by Chao1 index (p = 0.014). A significant decline in prevalence of the genera Bifidobacterium (p < 0.001), Lаchnоsріra (p = 0.032), Roseburia (p = 0.003), Соррососcus (p = 0.012) was established along with rise in Ruminососсus (p < 0.001) and Кlebsiеllа (p = 0.002) in women with RPL. Moreover, there were observed several significant relations: а positive correlation between abundance of Ruminococcus bacteria and TNF-α level (r = 0.49; p = 0.003), a negative correlation between abundance of Bifidobacterium and IL-17 (r = –0.54; p = 0.001), abundance of Lachnospira and cortisol level (r = –0.46; p = 0.002), as well as abundance of Coprococcus and melatonin level in blood serum (r = –0.58; p = 0.028).
Conclusion. It was found out that patients with RPL are characterized by dysbiotic changes in the microbiome landscape. The statistically significant correlations between some microbiota representatives and neuro-immune-humoral biomarkers suggest that dysbiotic alterations in the intestine may be involved in developing immune disorders and dysregulation of the pineal-pituitary-adrenal axis underlying RPL pathogenesis.
What is already known about this subject?
► Preeclampsia (PE) is a leading cause of maternal and fetal morbidity and mortality worldwide, affecting 2–8 % of pregnancies.
► Adolescent pregnancy is associated with a higher risk of PE due to immature reproductive organs and increased cardiovascular risk factors.
► Obesity is a well-known risk factor for PE, but its role in adolescent pregnancies remains unclear.
What are the new findings?
► This study found significant differences in age, gravida status, delivery mode, and low birth weight (LBW) between adolescent pregnancies with and without PE.
► PE in adolescent pregnancies is strongly associated with cesarean delivery and higher incidence of LBW neonates.
► Body mass index (BMI) alone is not a reliable predictor of PE in adolescent pregnancies, suggesting the need for further risk stratification.
How might it impact on clinical practice in the foreseeable future?
► Understanding the risk factors for PE in adolescent pregnancies may improve early detection and targeted interventions.
► More comprehensive risk stratification models, beyond BMI alone, are needed for predicting PE in young pregnant women.
► Increased awareness of the impact of PE on neonatal outcomes could guide obstetricians in optimizing prenatal care for adolescent pregnancies.
Introduction. Many risk factors including maternal age especially in adolescence pregnancy, gravidity, parity status, and body mass index (BMI) considered to play role in preeclampsia (PE) pathogenesis.
Aim: to analyze а relationship between numerous risk factors including BMI in adolescent pregnancies with PE, thereby gaining deeper insight into risk factors and PE impact in pregnant adolescents.
Materials and Methods. This was a cross-sectional study conducted in Hasan Sadikin General Hospital Bandung with adolescence pregnant women diagnosed with PE during 2019–2023 as the subject population. The minimum sample size was calculated using unpaired categorical analytical study sample size formula and 310 total research subjects were obtained. Data were analyzed using bivariate analysis with IBM SPSS v28 software.
Results. The results indicate significant differences in the proportions of age, gravida, gestational age, mode of delivery, and low birth weight infant between the preeclampsia and non-preeclampsia groups (p < 0.05). There were no significant differences in the proportions of extremely low birth weight, peripartum cardiomyopathy, HELLP syndrome, and pulmonary edema between the two groups (p > 0.05). No significant difference was found in the BMI proportions between the two groups (odds ratio (OR) = 1.361; 95 % confidence interval (CI) = 0.828–2.237; p = 0.223).
Conclusion. Many risk factors could play role in PE pathogenesis in adolescent pregnancies. BMI alone is not enough to be PE predictor. Further studies are needed regarding risk stratification of adolescent pregnancy in a more comprehensively.
REVIEW ARTICLES
What is already known about this subject?
► Severe ovarian hyperstimulation syndrome (OHSS) is considered as the leading etiopathogenetic factor for thromboembolic complications during in vitro fertilization (IVF) procedures.
► Detected hereditary and acquired thrombophilia including factor V Leiden and prothrombin G20210A mutations as well as antiphospholipid syndrome are associated with increased thrombosis risk during ovulation stimulation, particularly in female patients with comorbidities.
► Compared with fresh IVF cycles, transfer of cryopreserved embryos is coupled to substantially lower risk of venous thromboembolic complications due to the lack of exposure to high estrogen concentrations and prevented OHSS development.
What are the new findings?
► It has been first emphasized about a role for hyperhomocysteinemia (ННС) as an independent risk factor for venous thrombosis in IVF cycles that may underlie its introduction into screening algorithms.
► Taking into account the nature of ovulation stimulation, detected OHSS and associated risk factors (including thrombophilia and metabolic disorders) justify a need for a differentiated approach to thromboprophylaxis.
► A pathogenic relationship has been established between the type of transferred embryo (fresh or cryopreserved) and venous thromboembolism (VTE) rate in the first trimester of pregnancy particularly in women with thrombophilia. It allows for refining tactics of assisted reproductive technologies (ART).
How might it impact on clinical practice in the foreseeable future?
► The introduction of routine screening for thrombophilia in women planning IVF may facilitate risk stratification and determine indications for thrombosis prevention, even prior to onset of hormonal stimulation.
► The utilization of cryotransfer procedure in patients exhibiting elevated thrombotic risk may emerge as a favored stratagem, thereby minimizing VTE probability without compromising efficacy of IVF programs.
► Introduction of metabolic profile factors such as obesity and ННС into thrombotic risk assessment may expand opportunities for personalized selection of ART tactics and preventive measures.
Here, we review the current data on the relationship between in vitro fertilization (IVF) procedures and thrombotic complications by focusing on epidemiological, pathophysiological and clinical aspects. Although being a rare IVF complication (incidence is about 0.2 %), thrombosis poses a serious threat especially in patients with ovarian hyperstimulation syndrome (OHSS). The risk of thrombotic complications in OHSS is elevated markedly thereby underscoring the need for careful monitoring and prevention. Despite that arterial thrombosis is less common than venous thrombosis, it is more often associated with OHSS and arise early after ovarian stimulation. IVF is also characterized by atypical thrombosis localization targeting upper limbs, neck and cerebral veins. The risk of thrombogenesis peaks in the first trimester of IVF-related pregnancy and can persist for several weeks after OHSS resolution. Key risk factors for thrombotic complications include OHSS that elevates thrombosis risk by 100-fold; thrombophilia (both hereditary and acquired), especially in women with multiple risk factors; obesity associated with increased estrogens and procoagulant factors level; maternal age > 35 years; polycystic ovary syndrome, which increases VTE risk by five-fold. Special attention is paid to strategies for reducing the risk of thrombotic complications. Compared to fresh embryo transfer, use of revitalized embryos can prominently lower thrombosis risk due to the lack of markedly increased estrogen levels and elimination of OHSS risk.
What is already known about this subject?
► Contemporary anti-tumor therapy, such as chemotherapy, hormonal therapy, and radiation therapy, can negatively affect reproductive function. The issue of preserving fertility in women with breast cancer (BC) has been increasingly important due to the growing number of young BC patients.
► Chemotherapy can reduce ovarian reserve, cause premature menopause, and lead to infertility. Hormonal therapy can also affect fertility, although its effects are less pronounced. Radiation therapy rarely causes loss of fertility directly, but it may require specific protection.
► Various methods to preserve fertility, such as egg and embryo cryopreservation, as well as temporary suppression of ovarian function using gonadotropin-releasing hormone agonists (аGnRH) are underway. These methods help BC women preserve an opportunity to become mothers in the future.
What are the new findings?
► The key strategies used to prevent loss of fertility have been systematized, including egg and embryo cryopreservation, ovarian tissue cryopreservation, and аGnRH-based temporary suppression of ovarian function.
► The significance of long-term observation of children born by using preserved gametes and tissues to evaluate the safety and effectiveness of the applied methods has been noted.
How might it impact on clinical practice in the foreseeable future?
► Translation of fertility preservation methods into clinical practice may significantly impact on BC treatment in the near future. Firstly, it will allow physicians to offer more personalized treatment plans taking into account patients’ reproductive desires and needs.
► The application of methods such as egg and embryo cryopreservation, as well as temporary suppression of ovarian function, may reduce fear of losing ability to conceive, which in turn will improve patients’ psychoemotional state and increase adherence to treatment.
► In the long term, further development and advancement of fertility preservation methods may result in creation of more effective and safer treatment protocols exerting lower impact on reproductive function. This will help increase the number of women who retain the ability to conceive and give birth to a healthy baby after completing BC treatment.
The article discusses current methods for preserving fertility in women undergoing breast cancer (BC) treatment. It provides a detailed overview of contemporary breast cancer treatments and their impact on fertility. To prevent fertility loss, there are described key strategies such as oocyte, embryo, and ovarian tissue cryopreservation, as well as temporary suppression of ovarian function using gonadotropin-releasing hormone agonists. In addition, it analyzes factors such as lack of information, limited medical resources, and the need for immediate anticancer therapy initiation that hinder access to such methods. The importance of comprehensive patient support systems involving coordination among oncologists, reproductive specialists, and psychologists is emphasized. Special attention is paid to further development and improvement of existing methods aimed at reducing gonadotoxicity, as well as ongoing research to identify new safe and effective strategies. It is specifically stressed about importance of long-term monitoring of children born from preserved gametes and tissues to assess the safety and efficacy of such approaches. Integrating fertility preservation into the overall BC treatment strategy can markedly improve women's quality of life by increasing their chances of regaining reproductive function after completing primary treatment.
What is already known about this subject?
► The prevalence of pelvic organ prolapse (POP) ranges from 3 to 50 % and is accompanied by a number of anatomical, topographic and functional disorders of the pelvic floor and pelvic organs, leading to reduced women’ performance and quality of life.
► The pelvic floor muscles support the pelvic organs in the correct position relative to the body vertical axis, ensure the closing and retaining functions for vaginal, urethral and anal orifices. The closing apparatus of the vagina in animals is presented by the circular muscle lacked in humans.
► The pelvic floor consists of the three muscle layers – superficial, middle and deep, the anatomical location of which is described by indicating their attachment points. The presentation of the muscle complex for closing vagina is controversial due to the lack of a common functional terminology.
What are the new findings?
► Unlike animals, women’s urethral and rectal closing apparatus is presented by internal and external sphincters; the muscle complex that compresses the genital fissure and the lower third of the vagina consists of 5 muscles, which collectively ensure a closing function.
► M. bulbospongiosus and m. transverses perinei superficialis of the superficial layer of the pelvic floor, keep the genital fissure closed. M. sphincter urethrovaginalis, in the middle layer, narrows the urethra and vagina. M. pubovaginalis and m. puborectalis (medial legs of m. levator ani) in the deep layer, compress the lower third of the vagina.
► The muscles that close the vagina are anatomically connected with the adjacent pelvic organs due to their common embryonic development, and the disruption of their anatomy and function in POP contributes to developing urinary and anal incontinence, despite sphincters integrity.
How might it impact on clinical practice in the foreseeable future?
► A secure theoretical basis for understanding the anatomy and function of women’ pelvic floor muscles will facilitate development and implementation of standardized terminology, improvement and provision of higher quality research and medical care.
► Knowledge of anatomy and capacity to determine functional disorders of the supporting and closing muscle complex of the pelvic floor is of fundamental importance for timely identification of risk groups and effectiveness of both surgical and conservative treatment.
Introduction. In modern literature, the pelvic floor muscles are presented by showing their anatomical location and indicating relevant attachment points, but their combined anatomical, topographic and functional significance is described insufficiently, which the current review was aimed at.
Aim: to determine the physiological significance and anatomical units of the vagina occlusor muscle complex, topography and functions in health and in pelvic organ prolapse (POP).
Materials and Methods. The search for English-published literary sources was conducted in the international publication databases PubMed/MEDLINE, Google Scholar, Cochrane Library, and Russian-language eLibrary resource by using keywords «pelvic floor», «genital fissure», «vagina», «sphincters», «pelvic organ prolapse», «urinary incontinence», «anal incontinence» with unlimited search depth. The inclusion eligibility criteria were as follows: systematic reviews, full-text original studies examining pelvic floor anatomy and physiology containing the results of pathological, clinical and instrumental methods devoted to the anatomy and physiology of the pelvic floor, as well as monographs and textbooks. Total 53 publications were included in the descriptive review.
Results. Unlike animals, as well as the closing apparatus of the urethra and rectum consisting of internal and external sphincters, the muscle complex that compresses the genital slit and the lower third of the vagina includes five muscles. The m. bulbospongiosus of the superficial layer of the pelvic floor and m. transversus perinei superficialis, located in the perineal body, allow to keep the genital fissure closed. The external urethral sphincter located in the middle layer covers the ventral surface of the urethra and ensheath the distal part of the vagina, forming m. sphincter urethrovaginalis, that contracts to narrow both the urethra and the vagina. The deep layer is presented by m. levator ani, the medial and anterior bundles of which – m. pubovaginalis, pass along the sides of the vagina, whereas the m. puborectalis located laterally bends around the rectum as a U-shaped muscular sling – both of them close the gap between the medial legs of m. levator ani, narrowing the lower third of the vagina. All of such muscles have a close anatomical connection with adjacent organs due to their common embryonic development, and determine the stability and functional activity of the entire pelvic organs complex. Altering integrity of the specified muscle complex (rupture, in-labour overstretching) or its structural degradation characterized by loss of tone and contraction force, results in failed closing genital fissure, increased distance between the medial parts of m. levator ani in the lower third of the vagina and the loss of supporting and closing functions of the pelvic floor as well as POP development. Moreover, dysfunction of the constrictor muscles anatomically associated with neighbouring organs due to their common embryonic development, contributes to emergence of urinary and anal incontinence, despite the integrity of relevant sphincters.
Conclusion. The muscle complex that compresses the genital fissure and the lower third of the vagina is characterized by the lack of the circularmuscle and consists of five muscles having a close anatomical connection with adjacent pelvic organs. Damage to this muscle complex results in combined anatomical, topographic and functional changes in the pelvic floor, manifested by descent/prolapse of the pelvic organs and urinary/anal incontinence.
What is already known about this subject?
► Subjectivity, which often occurs at various stages of in vitro fertilization (IVF), reduces its effectiveness. In this regard, the introduction of principles of objectivity and effectiveness is a promising way to improve IVF outcomes. Artificial intelligence (AI) technologies can play an important role in solving this problem.
► AI-based digital platforms can become effective tools for automating and monitoring quality of treatment. In general, it has a great potential to improve both clinical results and the effectiveness of embryologist work, which is especially important upon growing country-widedemand for IVF procedures.
What are the new findings?
► Machine learning algorithms can process the image of embryos to assess their quality, which contributes to the selection of the viable among them for transfer.
► There are ethical and technical obstacles that prevent the widespread adoption of AI in clinical practice. Data privacy issues and the need to train specialists to deal with new technologies are also of concern.
► AI can analyze extensive datasets, including medical records and research results, to more accurately predict pregnancy outcomes. This allows doctors to make more justified clinical decisions.
How might it impact on clinical practice in the foreseeable future?
► In the foreseeable future, AI can significantly transform the clinical practice of reproductive medicine by improving the process of diagnostics and treatment of infertility.
► Multimodal models that combine different data types can significantly improve the accuracy of predicting pregnancy outcomes.
► AI can improve patient management by optimizing doctors’ appointments, monitoring health conditions, and providing personalized lifestyle recommendations.
Given the increasing problem of infertility in the Russian Federation, assisted reproductive technologies (ART) have proven to be one of the most effective treatments for this condition. Notably, the introduction of ART methods, particularly in vitro fertilization (IVF), has led to markedly increased birth rates over the past two decades. Studies show that machine learning algorithms can process images of embryos to assess their quality, thus facilitating the selection of the most viable among them for transfer. There are ethical and technical barriers hindering the widespread adoption of artificial intelligence (AI) in clinical practice, including concerns over data privacy as well as a need to train specialists to deal with new technologies. AI can analyze vast amounts of data, including medical histories and research results, to more accurately predict pregnancy outcomes. This enables doctors to make more justified clinical decisions. In the future, AI algorithms will be able to analyze patient data more efficiently, helping to identify the causes of infertility at earlier stages.
What is already known about this subject?
► The complement system is an important arm of the immune system, playing a crucial role in protecting the body and regulating the inflammatory response. It consists of more than 30 proteins that interact with one another, forming a cascade of reactions that contribute to pathogens destruction, inflammation, as well as activation of other immune components.
► The complement system ensures the maintenance of homeostasis and the regulation of the immune response. The products of the complement activation perform functions that promote antiseptic effects in vivo while simultaneously preventing excessive inflammatory reactions.
► Women with preeclampsia (РЕ) exhibit increased activation of specific complement components, which may lead to the activation of inflammatory processes and damage to the endothelial lining of blood vessels.
What are the new findings?
► Activation of the complement system, particularly components C3 and C5, occurs in placental tissue and triggers inflammatory responses, which in turn enhances vascular permeability. It not only exacerbates РЕ clinical manifestations but may also lead to systemic complications.
► Clinical studies are aimed at identifying molecular and genetic markers that can predict the risk of developing РЕ associated with complement dysfunction. This opens up new opportunities for preventive strategies for high-risk women.
How might it impact on clinical practice in the foreseeable future?
► Research in this field is underway, so that its findings may unveil new approaches to PE diagnostics and treatment, as well as gain deeper understanding of the mechanisms involved in regulating pregnancy-related immune response.
► Unregulated complement activation – a threat to pregnancy. One of the key aspects is the necessity of integrating multidisciplinary strategies aimed at both the early detection and the effective management of potential complications.
► The implementation of methods aimed at monitoring the levels of specific markers related to systemic inflammatory response may become an important step towards РЕ prevention.
Here, we discuss current theories regarding preeclampsia (PE) pathogenesis, a role of the complement system in PE onset and evaluate an impact of altered complement system on pregnancy outcomes and PE severity. The studies conducted in the field of preeclampsia have indeed raised numerous new scientific questions and hypotheses. One of the key questions is whether the complement system activation is the primary PE cause or just a consequence of one or more pathological processes linked to this syndrome.
FROM HISTORY
This article highlights key stages in the life and career of the British surgeon Patrick Christopher Steptoe, who played a key role in the development of assisted reproductive technologies. Having started his career as a laparoscopy specialist, Dr. Steptoe developed minimally invasive methods for retrieving oocytes, which became critical to the success of in vitro fertilization. In collaboration with Robert Edwards, Dr. Steptoe performed the first successful IVF procedure, which in 1978 resulted in the birth of Louise Brown, the world's first test-tube baby. Innovative surgical techniques proposed by Dr. Steptoe laid the foundation for current IVF protocols.
EVENTS

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
ISSN 2500-3194 (Online)